Associate Professor, Neurology, University of Kentucky College of Medicine
Neurology
Dr. Gregory A. Jicha, MD
|
|
Give Review
Gregory A. Jicha, MD is an expert in the field of Neurology. He went to medical school at Albert Einstein College of Medicine of Yeshiva University. He received awards:"Regional Top Doctor". Gregory Jicha has written publications. He has 83 publications published with PubMed. The lastest publication is: 'Hierarchical phosphorylation of recombinant tau by the paired-helical filament-associated protein kinase is dependent on cyclic AMP-dependent protein kinase.' Gregory A. Jicha is registered with Medicare.
Publications
- Peripheral (deep) but not periventricular MRI white matter hyperintensities are increased in clinical vascular dementia compared to Alzheimer's Disease.
- Rural-Urban Differences in Alzheimer's Disease and Related Disorders Diagnostic Prevalence in Kentucky and West Virginia.
- Cerebrospinal Fluid Vascular Endothelial Growth Factor.
- Rarity of the Alzheimer Disease-Protective APP A673T Variant in the United States.
- Primary age-related tauopathy (PART): a common pathology associated with human aging.
- Effects of Multiple Genetic Loci on Age at Onset in Late-Onset Alzheimer Disease: A Genome-Wide Association Study.
- ABCC9 gene polymorphism is associated with hippocampal Sclerosis of aging pathology.
- Advancing research diagnostic criteria for Alzheimer's Disease: the IWG-2 criteria.
- Diagnostic accuracy and practice effects in the National Alzheimer's Coordinating Center Uniform Data Set neuropsychological battery.
- Spectral and complexity analysis of scalp EEG characteristics for mild cognitive impairment and early Alzheimer's Disease.
- Frontal white matter integrity in adults with Down Syndrome with and without dementia.
- Musical Training and Late-Life Cognition.
- Arteriolosclerosis that affects multiple Brain regions is linked to hippocampal sclerosis of ageing.
- Repeated retrieval during working memory is sensitive to amnestic mild cognitive impairment.
- Hippocampal sclerosis of aging, a prevalent and high-morbidity brain Disease.
- APOE-ε2 and APOE-ε4 correlate with increased amyloid accumulation in Cerebral vasculature.
- Dysregulation of leptin signaling in Alzheimer Disease: evidence for neuronal leptin resistance.
- Adjusting for Mortality when Identifying Risk Factors for Transitions to Mild Cognitive Impairment and Dementia.
- Resting EEG Discrimination of Early Stage Alzheimer's Disease from Normal Aging Using Inter-Channel Coherence Network Graphs.
- Cognitive and brain reserve and the diagnosis and treatment of preclinical Alzheimer Disease.
- Substantia nigra depigmentation and exposure to encephalitis lethargica.
- Attention-Deficit/Hyperactivity Disorder in Older Adults: Prevalence and Possible Connections to Mild Cognitive Impairment.
- Differential reports of Pain and depression differentiate mild cognitive impairment from cognitively intact elderly participants.
- Serum antibodies to periodontal pathogens are a risk factor for Alzheimer's Disease.
- Mild cognitive impairment: statistical models of transition using longitudinal clinical data.
- University of Kentucky Sanders-Brown Healthy Brain Aging Volunteers: Donor Characteristics, Procedures, and Neuropathology.
- Alzheimer Disease: Can the exam predict the pathology?
- Blood serum miRNA: Non-invasive biomarkers for Alzheimer's Disease.
- Medical Management of Frontotemporal Dementias: The Importance of the Caregiver in Symptom Assessment and Guidance of Treatment Strategies.
- Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's Disease.
- Preclinical AD Workgroup staging: pathological correlates and potential challenges.
- Prediction of Preclinical Alzheimer's Disease: Longitudinal Rates of Change in Cognition.
- "End-Stage" Neurofibrillary Tangle Pathology in Preclinical Alzheimer's Disease: Fact or Fiction?
- Management of frontotemporal dementia: targeting symptom management in such a heterogeneous Disease requires a wide range of therapeutic options.
- Comparison of recruitment efforts targeted at primary care physicians versus the community at large for participation in Alzheimer Disease clinical trials.
- Conceptual Evolution in Alzheimer's Disease: Implications for Understanding the Clinical Phenotype of Progressive Neurodegenerative Disease.
- Lewy body pathology in normal elderly subjects.
- Brains with medial temporal lobe neurofibrillary tangles but no neuritic amyloid plaques are a diagnostic dilemma but may have pathogenetic aspects distinct from Alzhe...
- Clinicopathologic correlations in a large Alzheimer Disease center autopsy cohort: neuritic plaques and neurofibrillary tangles "do count" when staging Disease severity.
- EEG changes in a patient with steroid-responsive encephalopathy associated with antibodies to thyroperoxidase (SREAT, Hashimoto's encephalopathy).
- Argyrophilic grain Disease in demented subjects presenting initially with amnestic mild cognitive impairment.
- Neuropathologic outcome of mild cognitive impairment following progression to clinical Dementia.
- Neuropathologic features of amnestic mild cognitive impairment.
- Depression, apolipoprotein E genotype, and the incidence of mild cognitive impairment: a prospective cohort study.
- Pseudotumor cerebri reversed by cardiac septal defect repair.
- Dendritic changes in Alzheimer''s Disease and factors that may underlie these changes.
- Hierarchical phosphorylation of recombinant tau by the paired-helical filament-associated protein kinase is dependent on cyclic AMP-dependent protein kinase.
- Altered conformation of recombinant frontotemporal Dementia-17 mutant tau proteins.
- Sequence requirements for formation of conformational variants of tau similar to those found in Alzheimer's Disease.
- cAMP-dependent protein kinase phosphorylations on tau in Alzheimer's Disease.
- Nutrition and prevention of Alzheimer's Dementia.
- Sugihara causality analysis of scalp EEG for detection of early Alzheimer's Disease.
- Discrimination of mild cognitive impairment and Alzheimer's Disease using transfer entropy measures of scalp EEG.
- Alzheimer's Biomarkers are Correlated with Brain Connectivity in Older Adults Differentially during Resting and Task States.
- Attention-deficit/hyperactivity disorder in childhood is associated with cognitive test profiles in the geriatric population but not with mild cognitive impairment or ...
- Task deactivation reductions and atrophy within parietal default mode regions are overlapping but only weakly correlated in mild cognitive impairment.
- Alzheimer''s Disease is not "brain aging": neuropathological, genetic, and epidemiological human studies.
- Hippocampal Sclerosis in advanced age: clinical and pathological features.
- Conceptual evolution in Alzheimer''s Disease: implications for understanding the clinical phenotype of progressive neurodegenerative Disease.
- Functional response in ventral temporal cortex differentiates mild cognitive impairment from normal aging.
- Omega-3 fatty acids: potential role in the management of early Alzheimer''s Disease.
- Association between male gender and cortical Lewy body pathology in large autopsy series.
- Revising the definition of Alzheimer''s Disease: a new lexicon.
- Low sensitivity in clinical diagnoses of Dementia with Lewy bodies.
- Relative preservation of MMSE scores in autopsy-proven Dementia with Lewy bodies.
- Age-related slowing of task switching is associated with decreased integrity of frontoparietal white matter.
- Age and apoE associations with complex pathologic features in Alzheimer''s Disease.
- Clinical features of mild cognitive impairment differ in the research and tertiary clinic settings.
- Human Cerebral neuropathology of Type 2 diabetes mellitus.
- Alzheimer''s-type neuropathology in the precuneus is not increased relative to other areas of neocortex across a range of cognitive impairment.
- Modeling the association between 43 different clinical and pathological variables and the severity of cognitive impairment in a large autopsy cohort of elderly persons.
- Prodromal clinical manifestations of neuropathologically confirmed Lewy body Disease.
- Acetylcholinesterase inhibitor treatment is associated with relatively slow cognitive decline in patients with Alzheimer''s Disease and AD + DLB.
- Aging influences the neural correlates of lexical decision but not automatic semantic priming.
- Is passive immunization for Alzheimer''s Disease ''alive and well'' or ''dead and buried''?
- Primary diffuse leptomeningeal gliomatosis.
- Brain structural alterations before mild cognitive impairment.
- Research criteria for the diagnosis of Alzheimer''s Disease: revising the NINCDS-ADRDA criteria.
- Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau.
- Assessing the discriminant ability, reliability, and comparability of multiple short forms of the Boston Naming Test in an Alzheimer's Disease center cohort.
- Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's Disease brain.
- A conformation- and phosphorylation-dependent antibody recognizing the paired helical filaments of Alzheimer's Disease.
Schools
Albert Einstein College of Medicine of Yeshiva University
Procedures Preformed
- EEG (Electroencephalogram)
Conditions Treated
- Alzheimer's Disease
- Anterior Horn Disease
- Ataxia
- Autonomic Disorders
- View All
Doctors Specialties
- Neurology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Pathway X Ind Direct Access KY
- Anthem Blue Cross Blue Shield HMO
- Anthem Blue Cross Blue Shield PPO
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Cigna HMO
- Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Coventry Health Care
- Choice Care PPO
- Preferred PPO
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Mutual of Omaha
- Sagamore Plus
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
- Universal American
Awards
- Regional Top Doctor
Education
-
Mayo School of Graduate Medical Education -
Albert Einstein College of Medicine of Yeshiva University
Hospital
-
University of Kentucky Albert B. Chandler Hospital
Drug Facts
| NPI NUMBER | 1619073202 | |
| NPPES Provider LastName | JICHA | |
| NPPES Provider FirstName | GREGORY | |
| NPPES Provider ZIPCode | 405360001 | |
| NPPES Provider State | KY | |
| Specialty Description | Neurology | |
| Total Claim Count | 2646.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1619073202 |
| Last Name Of The Provider | JICHA |
| First Name Of The Provider | GREGORY |
| View All |
Similar Doctors
|
|
Dr. Sourabh Lahoti, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ryan H. Patrick, MD |
|
|
Dr. Nicole A. Everman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alexander J. Tikhtman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. George W. Privett Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James M. Thompson, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Toufic A. Fakhoury, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Abdullah Al Sawaf, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph L. Zerga III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Luther C. Pettigrew, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Efrat Feldman, MD |
|
|
Pradeep K. Panuganti, MB |